Developing ethics guidance for HIV prevention research: the HIV Prevention Trials Network approach: Table 1
- 26 November 2010
- journal article
- research article
- Published by BMJ in Journal of Medical Ethics
- Vol. 36 (12) , 810-815
Abstract
More than 25 years into the HIV epidemic, in excess of 2 million new infections continue to occur each year. HIV prevention research is crucial for groups at heightened risk for HIV, but the design and conduct of HIV prevention research with vulnerable populations worldwide raises considerable ethical challenges. The HIV Prevention Trials Network (HPTN) is a global collaborative network that conducts clinical and behavioural studies on non-vaccine interventions to reduce the transmission of HIV. In 2003, the HPTN developed ethical guidance to enhance the responsible conduct of its research activities and as a distinctive contribution to global research ethics. In what follows, the developments that motivated the drafting of a revised ethics document in 2009 are described, including the process by which that revision took place and some of the key differences between the HPTN ethics guidance and other relevant guidelines in the field.Keywords
This publication has 8 references indexed in Scilit:
- International perspectives on the collection, storage, and testing of human biospecimens in HIV research.2008
- Standard of care: an evolution in ethical thinkingThe Lancet, 2008
- Pregnancy Prevention Practices Among Women With Multiple Partners in an HIV Prevention TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Community perspectives on care options for HIV prevention trial participantsAIDS Care, 2007
- Women's Autonomy and Informed Consent in Microbicides Clinical TrialsJournal of Empirical Research on Human Research Ethics, 2006
- The Balm of Gilead: Is the Provision of Treatment to Those Who Seroconvert in HIV Prevention Trials a Matter of Moral Obligation or Moral Negotiation?Journal of Law, Medicine & Ethics, 2006
- Ethical issues in HIV/AIDS research.2005
- Ethics guidance for HIV prevention trialsBMJ, 2003